Clinical Trial Design Considerations to Improve Equitable Anti-Obesity Medication Access for Youth
Diabetes Care · 01.06.2026 · 49 (6) · 934-936
DOI: 10.2337/dci25-0129 ↗Kurz gefasst
Editorial in der Zeitschrift Diabetes Care, online erschienen am 20.05.2026. Verfasst von Jaime M Moore und 1 weiteren Autor:innen. Beteiligte Einrichtung: Section of Nutrition, Department of Pediatrics, University of Colorado Anschutz School of Medicine, Aurora, CO. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Section of Nutrition, Department of Pediatrics, University of Colorado Anschutz School of Medicine, Aurora, CO.
- Children's Hospital Colorado, Aurora, CO.
- Section of Endocrinology, Department of Pediatrics, University of Colorado Anschutz School of Medicine, Aurora, CO.
ORCID-Profile: Megan M Kelsey
Zitieren
APA
Moore, J. M., & Kelsey, M. M. (2026). Clinical Trial Design Considerations to Improve Equitable Anti-Obesity Medication Access for Youth. Diabetes Care, 49(6), 934-936. https://doi.org/10.2337/dci25-0129
Vancouver
Moore JM, Kelsey MM. Clinical Trial Design Considerations to Improve Equitable Anti-Obesity Medication Access for Youth. Diabetes Care. 2026;49(6):934-936. doi:10.2337/dci25-0129
BibTeX
@article{Moore2026,
author = {Moore, Jaime M and Kelsey, Megan M},
title = {Clinical Trial Design Considerations to Improve Equitable Anti-Obesity Medication Access for Youth},
journal = {Diabetes Care},
year = {2026},
volume = {49},
number = {6},
pages = {934--936},
doi = {10.2337/dci25-0129}
}
EUVIMED